Progesterone Receptor-B Induction of BIRC3 Protects Endometrial Cancer Cells from AP1-59-Mediated Apoptosis

Progesterone is a growth inhibitory hormone in the endometrium. While progestins can be used for the treatment of well-differentiated endometrial cancers, resistance to progestin therapy occurs for reasons that remain unclear. We have previously demonstrated that progesterone receptors (PR) A and B...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Neubauer, Nikki L., Ward, Erin C., Patel, Parin, Lu, Zhenxiao, Lee, Irene, Blok, Leen J., Hanifi-Moghaddam, Payman, Schink, Julian, Kim, J. Julie
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3133609/
https://ncbi.nlm.nih.gov/pubmed/21760855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12672-011-0065-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller